Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Pisters

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|June 13, 2012
Peri-procedural antithrombotic bridging and the assessment of the associated risk of major bleedingIone Limantoro, Ron Pisters
Nature Reviews. Cardiology|May 28, 2009
Atrial fibrillation: A risk score for AF-burning the haystack to find the needleRon Pisters, Harry J Crijns
The Canadian Journal of Cardiology|July 24, 2012
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?Ron Pisters, Gregory Y H Lip
Current Heart Failure Reports|December 12, 2012
Safety and efficacy of new anticoagulants in patients with heart failureRon Pisters, Gregory Y H Lip
The New England Journal of Medicine|September 25, 2009
Clopidogrel plus aspirin in atrial fibrillationRon Pisters, Trang Dinh, Harry J Crijns
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 13, 2012
The impact of atrial fibrillation on quality of life of the elderly: the calm before the storm?Ione Limantoro, Bob Weijs, Harry Crijns, et al.
Advances in Cardiology|August 22, 2012
Challenges in atrial fibrillationRon Pisters, Hugo Ten Cate, Harry J Crijns
The Cochrane Database of Systematic Reviews|June 15, 2012
Anticoagulation versus placebo for heart failure in sinus rhythmGregory Yh Lip, Benjamin J Wrigley, Ron Pisters
JACC. Clinical Electrophysiology|May 17, 2018
Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European PopulationAndrew D Blann, Ron Pisters, Gregory Y H Lip
The Cochrane Database of Systematic Reviews|May 4, 2016
WITHDRAWN: Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmGregory Y H Lip, Benjamin J Wrigley, Ron Pisters
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|June 13, 2012
Peri-procedural antithrombotic bridging and the assessment of the associated risk of major bleedingIone Limantoro, Ron Pisters
Nature Reviews. Cardiology|May 28, 2009
Atrial fibrillation: A risk score for AF-burning the haystack to find the needleRon Pisters, Harry J Crijns
The Canadian Journal of Cardiology|July 24, 2012
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?Ron Pisters, Gregory Y H Lip
Current Heart Failure Reports|December 12, 2012
Safety and efficacy of new anticoagulants in patients with heart failureRon Pisters, Gregory Y H Lip
The New England Journal of Medicine|September 25, 2009
Clopidogrel plus aspirin in atrial fibrillationRon Pisters, Trang Dinh, Harry J Crijns
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 13, 2012
The impact of atrial fibrillation on quality of life of the elderly: the calm before the storm?Ione Limantoro, Bob Weijs, Harry Crijns, et al.
Advances in Cardiology|August 22, 2012
Challenges in atrial fibrillationRon Pisters, Hugo Ten Cate, Harry J Crijns
The Cochrane Database of Systematic Reviews|June 15, 2012
Anticoagulation versus placebo for heart failure in sinus rhythmGregory Yh Lip, Benjamin J Wrigley, Ron Pisters
JACC. Clinical Electrophysiology|May 17, 2018
Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European PopulationAndrew D Blann, Ron Pisters, Gregory Y H Lip
The Cochrane Database of Systematic Reviews|May 4, 2016
WITHDRAWN: Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmGregory Y H Lip, Benjamin J Wrigley, Ron Pisters
Pageof 8